SP

Shoshana L. Posy

BS Bristol-Myers Squibb: 32 patents #102 of 3,969Top 3%
UM Universite De Montreal: 7 patents #14 of 428Top 4%
📍 Highland Park, NJ: #8 of 409 inventorsTop 2%
🗺 New Jersey: #2,003 of 69,400 inventorsTop 3%
Overall (All Time): #111,025 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 26–32 of 32 patents

Patent #TitleCo-InventorsDate
10457681 Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor Ian S. Young, Sanjeev Gangwar, Yam B. Poudel, Prasanna Sivaprakasam 2019-10-29
10428077 Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation Jacques Banville, Roger Remillard, Edward H. Ruediger, Daniel H. Deon, Marc Gagnon +7 more 2019-10-01
10238638 Benzothiazole and benzothiophene compounds Edward H. Ruediger, Daniel H. Deon, Marc Gagnon 2019-03-26
10047103 Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation Jacques Banville, Roger Remillard, Edward H. Ruediger, Daniel H. Deon, Marc Gagnon +7 more 2018-08-14
9862730 Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation R. Michael Lawrence, Michael M. Miller, Dietmar Seiffert, Pancras C. Wong, Jacques Banville +7 more 2018-01-09
9688695 Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation Jacques Banville, Roger Remillard, Edward H. Ruediger, Daniel H. Deon, Marc Gagnon +7 more 2017-06-27
9518064 Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation Alain Martel, François Tremblay, Anne Marinier, Eldon Scott Priestley, R. Michael Lawrence +1 more 2016-12-13